Renee Commerford

An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer

Joyce F. Liu, Howard A. Burris, Judy S. Wang et al. · Gynecologic Oncology · 2021 · 56 citations · Full text

Pharmacy, Oncology, Pharmacology +16

The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results

Gail D. Lewis Phillips, Guangmin Li, Jun Guo et al. · Nature Communications · 2024 · 46 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides

Michael H. Serrano‐Wu, Gary M. Coppola, Yongjin Gong et al. · ACS Medicinal Chemistry Letters · 2012 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The DGAT1 inhibitor Pradigastat Decreases Chylomicron Secretion and Prevents Postprandial Triglyceride Elevation in Humans

Charles D. Meyers, Michael H. Serrano‐Wu, Ahmed Amer et al. · Journal of clinical lipidology · 2013 · 24 citations

Life Sciences, Endocrinology, Pharmacology +12

Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans

Katsumasa Nakajima, Ricardo E. Chatelain, Kevin B. Clairmont et al. · Journal of Medicinal Chemistry · 2017 · 18 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17